Satellos Bioscience Inc. (MSCL.TO)

CAD 0.89

(-4.3%)

Total Debt Summary of Satellos Bioscience Inc.

  • Satellos Bioscience Inc.'s latest annual total debt in 2023 was - CAD , down 0.0% from previous year.
  • Satellos Bioscience Inc.'s latest quarterly total debt in 2024 Q1 was - CAD , down 0.0% from previous quarter.
  • Satellos Bioscience Inc. reported annual total debt of - CAD in 2022, down 0.0% from previous year.
  • Satellos Bioscience Inc. reported annual total debt of - CAD in 2021, down -100.0% from previous year.
  • Satellos Bioscience Inc. reported quarterly total debt of - CAD for 2024 Q1, down 0.0% from previous quarter.
  • Satellos Bioscience Inc. reported quarterly total debt of - CAD for 2023 FY, down 0.0% from previous quarter.

Annual Total Debt Chart of Satellos Bioscience Inc. (2023 - 2019)

Historical Annual Total Debt of Satellos Bioscience Inc. (2023 - 2019)

Year Total Debt Total Debt Growth
2023 - CAD 0.0%
2022 - CAD 0.0%
2021 - CAD -100.0%
2020 1.09 Million CAD 0.0%
2019 - CAD 0.0%

Peer Total Debt Comparison of Satellos Bioscience Inc.

Name Total Debt Total Debt Difference
Appili Therapeutics Inc. 8.18 Million CAD 100.0%
Eupraxia Pharmaceuticals Inc. 13.78 Million CAD 100.0%
Helix BioPharma Corp. - CAD NaN%
Microbix Biosystems Inc. 6.64 Million CAD 100.0%
Medicenna Therapeutics Corp. - CAD NaN%
Oncolytics Biotech Inc. 423 Thousand CAD 100.0%
Sernova Corp. 136.12 Thousand CAD 100.0%